NCT01319006View on ClinicalTrials.gov

Relative Bioavailability Study for GSK1278863A

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 25, 2011

Primary Completion Date

April 18, 2011

Study Completion Date

April 18, 2011

Conditions
Anaemia
Interventions
DRUG

GSK1278863A

100mg (x90=13um), oral tablet, single-dose with 7 day wash-out

DRUG

GSK1278863A

100mg (x90=29um), oral tablet, single-dose with 7 day wash-out

DRUG

GSK1278863A

100mg (x90=41um), oral tablet, single-dose with 7 day wash-out

Trial Locations (1)

78744

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01319006 - Relative Bioavailability Study for GSK1278863A | Biotech Hunter | Biotech Hunter